{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:25:33Z","timestamp":1791095133097,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s12194-025-00994-z","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T12:43:51Z","timestamp":1765802631000},"page":"176-189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of cone beam CT in personalization of bladder cancer radiotherapy"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2859-8728","authenticated-orcid":false,"given":"Geanina-Mirela","family":"Catona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana G.","family":"Marcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,15]]},"reference":[{"issue":"3","key":"994_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"994_CR2","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jmrs.532","volume":"68","author":"K Dower","year":"2021","unstructured":"Dower K, Ford A, Sandford M, Doherty A, Greenham S, Kerin L, et al. Retrospective evaluation of planning margins for patientsundergoing radical radiation therapy treatment for bladder cancer using volumetric modulated arc therapy and cone beam computed tomography. J Med Radiat Sci. 2021;68:371\u20138.","journal-title":"J Med Radiat Sci"},{"issue":"4","key":"994_CR3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s13566-019-00411-0","volume":"8","author":"AD Sherry","year":"2019","unstructured":"Sherry AD, Stewart A, Luo G, Kirschner AN. Intensity-modulated radiotherapy is superior to threedimensional conformal radiotherapy in the trimodality management of muscle-invasive bladder cancer with daily cone beam computed tomography optimization. J Radiat Oncol. 2019;8(4):395\u2013403.","journal-title":"J Radiat Oncol"},{"key":"994_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.prro.2013.07.008","volume":"4","author":"CD Biancia","year":"2014","unstructured":"Biancia CD, Yorke E, Kollmeier MA. Image guided radiation therapy for bladder cancer: assessment of bladder motion using implanted fiducial markers. Pract Radiat Oncol. 2014;4:108\u201315.","journal-title":"Pract Radiat Oncol"},{"key":"994_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.12659\/PJR.890745","volume":"79","author":"K Srinivasan","year":"2014","unstructured":"Srinivasan K, Mohammadi M, Shepherd J. Applications of linac-mounted kilovoltage cone-beam computed tomography in modern radiation therapy. Pol J Radiol. 2014;79:181\u201393.","journal-title":"Pol J Radiol"},{"key":"994_CR6","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170580","volume":"91","author":"V Kong","year":"2018","unstructured":"Kong V, Kwan M, Chen S, Chung P, Craig T, Rosewall T. Quantification of interobserver variability in image registration using cone beam CT for partial bladder radiotherapy\u2014a comparison between lipiodol and bladder wall surface. Br J Radiol. 2018;91:20180413.","journal-title":"Br J Radiol"},{"issue":"9","key":"994_CR7","volume":"16","author":"S Azzarouali","year":"2024","unstructured":"Azzarouali S, Goudschaal K, Visser J, Bel A, Dani\u00ebls L, den Boer D. Cone-beam computed tomography-guided online adaptive radiotherapy: promising results for bladder cancer case. Cureus. 2024;16(9):e68863.","journal-title":"Cureus"},{"key":"994_CR8","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.radonc.2022.03.014","volume":"171","author":"M Lina","year":"2022","unstructured":"Lina M, \u00c5str\u00f6m CP, Behrens L, Calmels D, Sj\u00f6str\u00f6m P, Geertsen LS, Mouritsen. Eva Serup-Hansen, Henriette Lindberg, Patrik Sibolt online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: initial experience and dosimetric benefits. Radiother Oncol. 2022;171:37\u201342.","journal-title":"Radiother Oncol"},{"key":"994_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/BLC-230056","volume":"9","author":"E Chang","year":"2023","unstructured":"Chang E, Hahnb NM, Lernerc SP, Fallaha J, Agrawala S, Kamatd AM, Bhatnagare V, Svatekf RS, Jaigirdarg AA, Brossg P, Shoreh N, Katesi M, Sachsej K, Brewera JR, O\u2019Donnellk MA, Steinberg GD, Vivianom CJ, et al. Advancing clinical trial design for Non-Muscle invasive bladder cancer. Bladder Cancer. 2023;9:271\u201386.","journal-title":"Bladder Cancer"},{"key":"994_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15041009","volume":"15","author":"CM Kensen","year":"2023","unstructured":"Kensen CM, Betgen A, Wiersema L, Peters FP, Kayembe MT, Marijnen CAM, et al. Online adaptive MRI-guided radiotherapy for primary tumor and lymph node boosting in rectal cancer. Cancers. 2023;15:1009.","journal-title":"Cancers"},{"key":"994_CR11","first-page":"54","volume":"18","author":"D Winkel","year":"2019","unstructured":"Winkel D, Bol GH, Kroon PS, Asselen B, Hackett SS, Werensteijn-Honingh AM, et al. Adaptive radiotherapy: the Elekta Unity MR-linac concept. Clin Transl Radiat Oncol. 2019;18:54\u20139.","journal-title":"Clin Transl Radiat Oncol"},{"key":"994_CR12","doi-asserted-by":"crossref","unstructured":"The International Commission on Radiation Units and Measurements. Journal of the ICRU 10(1), Report 83, Oxford University Press; 2010.","DOI":"10.1093\/jicru\/ndq001"},{"issue":"9","key":"994_CR13","first-page":"e1638","volume":"9","author":"A Kochan","year":"2017","unstructured":"Kochan A, Rivest R, Galloway K, Lambert P, Ong A, Koul R, Ahmed S, Bashir B, Quon H. Targeting the tumor: assessing the impact of bladder volume and position on accuracy of radiation delivery for patients with bladder cancer. Cureus. 2017;9(9):e1638.","journal-title":"Cureus"},{"key":"994_CR14","doi-asserted-by":"publisher","first-page":"4674","DOI":"10.3390\/cancers14194674","volume":"14","author":"YY Jo","year":"2022","unstructured":"Jo YY, Yea JW, Park J, Oh SA, Park JW. Optimized adaptive radiotherapy with individualized plan library for muscle-invasive bladder cancer using internal target volume generation. Cancers. 2022;14:4674.","journal-title":"Cancers"},{"key":"994_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13014-023-02348-8","volume":"18","author":"S Azzaroual","year":"2023","unstructured":"Azzaroual S, Goudschaal K, Visser J, Hulshof M, Admiraal M, van Wieringen N, et al. Online adaptive radiotherapy for bladder cancer using a simultaneous integrated boost and fiducial markers. Radiat Oncol. 2023;18:165.","journal-title":"Radiat Oncol"},{"key":"994_CR16","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.3390\/cancers17071194","volume":"17","author":"M Petrikowski","year":"2025","unstructured":"Petrikowski M, Kr\u00f6ger K, Roers J, Hering D, Lohmann S, Scobioala S, Haverkamp U, Eich TH. Can the dose constraints be trusted? Actual dose exposure of bladder and rectum during prostate cancer radiotherapy. Cancers. 2025;17:1194.","journal-title":"Cancers"},{"key":"994_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.radonc.2013.08.045","volume":"109","author":"A Vestergaard","year":"2013","unstructured":"Vestergaard A, Muren LP, S\u00f8ndergaard J, Elstr\u00f8m UV, H\u00f8yer M, Petersen JB. Adaptive plan selection vs. re-optimisation in radiotherapy for bladder cancer: a dose accumulation comparison. Radiother Oncol. 2013;109:457\u201362.","journal-title":"Radiother Oncol"},{"key":"994_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13014-019-1262-8","volume":"14","author":"R Jadon","year":"2019","unstructured":"Jadon R, Higgins E, Hanna L, Evans M, Coles B, Staffurth J. A systematic review of dose-volume predictors and constraints for late bowel toxicity following pelvic radiotherapy. Radiat Oncol. 2019;14:57.","journal-title":"Radiat Oncol"},{"key":"994_CR19","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.clon.2010.01.005","volume":"22","author":"T Guerrero Urbano","year":"2010","unstructured":"Guerrero Urbano T, Khoo V, Staffurth J, Normany A, Buffaz F, Jackson A, et al. Intensity-modulated radiotherapy allows escalation of the radiation dose to the pelvic lymph nodes in patients with locally advanced prostate cancer: preliminary results of a phase I dose escalation study. Clin Oncol. 2010;22:236\u201344.","journal-title":"Clin Oncol"},{"key":"994_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.clon.2014.09.016","volume":"27","author":"F McDonald","year":"2015","unstructured":"McDonald F, Watersz R, Gullifordx S, Hallz E, James N, Huddart RS. Defining bowel dose volume constraints for bladder radiotherapy treatment planning. Clin Oncol. 2015;27:22\u20139.","journal-title":"Clin Oncol"},{"key":"994_CR21","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2019.1627417","author":"AS Bertelsen","year":"2019","unstructured":"Bertelsen AS, Schytte T, M\u00f8ller PK, Mahmood F, Riis HL, Gottlieb KL, et al. First clinical experiences with a high field 1.5 T MR linac. Acta Oncol. 2019. https:\/\/doi.org\/10.1080\/0284186X.2019.1627417.","journal-title":"Acta Oncol"},{"key":"994_CR22","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.3390\/cancers15215272","volume":"15","author":"D Lee","year":"2023","unstructured":"Lee D, Renz P, Oh S, Hwang M-S, Pavord D, Yun KL, et al. Online adaptive MRI-guided stereotactic body radiotherapy for pancreatic and other intra-abdominal cancers. Cancers. 2023;15:5272.","journal-title":"Cancers"},{"key":"994_CR23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/1754-9485.13336","volume":"66","author":"J de Leon","year":"2022","unstructured":"de Leon J, Crawford D, Moutrie Z, Alvares S, Hogan L, Pagulayan C, et al. Early experience with MR-guided adaptive radiotherapy using a 1.5 T MR-Linac: first 6 months of operation using adapt to shape workflow. J Med Imaging Radiat Oncol. 2022;66:138\u201345.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"994_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1358487","author":"N Bassiri","year":"2024","unstructured":"Bassiri N, Bayouth J, Chuong MD, Kotecha R, Weiss Y, Mehta MP, et al. Quality assurance of an established online adaptive radiotherapy program: patch and software upgrade. Front Oncol. 2024. https:\/\/doi.org\/10.3389\/fonc.2024.1358487.","journal-title":"Front Oncol"},{"key":"994_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/acm2.13801","volume":"23","author":"K Kisling","year":"2022","unstructured":"Kisling K, Keiper TD, Branco D, Gwe-Ya G, Kevin K, Moore L, et al. Clinical commissioning of an adaptive radiotherapy platform: results and recommendations. J Appl Clin Med Phys. 2022;23:e13801.","journal-title":"J Appl Clin Med Phys"}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00994-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-025-00994-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00994-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:12:03Z","timestamp":1772262723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-025-00994-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["994"],"URL":"https:\/\/doi.org\/10.1007\/s12194-025-00994-z","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"value":"1865-0333","type":"print"},{"value":"1865-0341","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,15]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"N\/A. The Institutional Review Board of our radiotherapy department, assessed the current study and concluded that no approval is required as it did not enrol patients for the said study. This work analysed the data of patients that have been treated as per the normal medical protocol without any change induced by this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}